Neurocrine Biosciences Inc Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020
Revenue & cost
Revenue 2.95M33.50M77.41M53.14M2.92M19.80M15.00M15.00M451.20M788.10M1,045.90M
Cost of Revenue 1.25M4.89M7.43M
Gross Profit 13.75M446.31M780.67M
Operating items
Research & Development 33.72M31.15M30.95M37.16M39.25M46.42M81.49M94.29M121.83M160.52M
Selling, General & Administrative 14.36M13.27M12.46M13.44M13.35M17.99M32.48M68.08M169.91M248.93M354.06M
Restructuring Costs 2.56M
Other Operating Expenses 0.84M0.29M0.24M0.03M0.04M-0.00M1.25M4.94M361.74M882.90M
Operating Expenses 56.62M47.22M43.49M51.69M52.60M64.41M113.97M162.37M292.99M414.40M715.80M882.90M
Operating Income -53.67M-13.72M33.92M1.45M-49.68M-64.41M-94.20M-147.37M-131.36M36.90M72.28M
EBIT -53.67M-13.72M33.92M1.45M-49.68M-64.41M-94.20M-147.37M-131.36M36.90M72.28M
Non-operating items
Interest & Investment Income -1.45M1.54M0.43M0.49M0.40M0.63M1.93M6.28M8.34M15.48M19.21M
Other Non Operating Income 2.79M2.87M2.95M3.04M3.13M3.23M3.33M3.42M2.12M
Non Operating Income 2.63M5.75M3.65M3.58M3.59M3.87M5.27M6.28M-11.18M-15.05M-25.74M
Net income details
EBT -55.12M-12.18M34.36M1.94M-49.28M-63.78M-92.27M-141.09M-142.54M21.84M46.54M
Tax Provisions 0.73M9.53M
Profit After Tax -51.04M-7.97M37.57M5.03M-46.09M-60.54M-88.93M-141.09M-142.54M21.10M37.00M407.30M
Equity Income -12.99M
Income from Continuing Operations -55.12M-12.18M34.36M1.94M-49.28M-63.78M-92.27M-141.09M-142.54M21.11M37.01M
Consolidated Net Income -55.12M-12.18M34.36M1.94M-49.28M-63.78M-92.27M-141.09M-142.54M21.11M37.01M
Income towards Parent Company -55.12M-12.18M34.36M1.94M-49.28M-63.78M-92.27M-141.09M-142.54M21.11M37.01M
Net Income towards Common Stockholders -55.12M-12.18M34.36M1.94M-49.28M-63.78M-92.27M-141.09M-142.54M21.11M37.01M
Additional items
EPS (Basic) -1.30-0.150.680.08-0.69-0.81-1.05-1.63-1.620.230.404.38
EPS (Weighted Average and Diluted) -1.30-0.150.670.08-0.69-0.81-1.05-1.63-1.620.220.394.16
Shares Outstanding (Weighted Average) 39.21M54.86M55.26M66.38M67.34M76.01M86.20M86.87M88.49M90.68M92.09M93.43M
Shares Outstanding (Diluted Average) 39.14M52.82M56.35M66.95M66.99M74.58M84.50M86.71M92.66M95.40M97.20M97.80M
EBITDA -53.67M-9.22M37.53M5.11M-46.08M-60.82M-89.63M-140.43M-144.07M21.03M40.36M
Interest Expenses 19.52M30.53M31.96M
Tax Rate 3.34%20.48%